RECURRENT BREAST CANCER
Clinical trials for RECURRENT BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT BREAST CANCER trials appear
Sign up with your email to follow new studies for RECURRENT BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to control advanced breast cancer
Disease control Recruiting nowThis study tests a drug called alisertib combined with hormone therapy for people with a common type of advanced breast cancer (HR+, HER2-). The goal is to find the best dose and see if the combination can shrink tumors or slow the disease. About 150 adults whose cancer has worse…
Matched conditions: RECURRENT BREAST CANCER
Phase: PHASE2 • Sponsor: Puma Biotechnology, Inc. • Aim: Disease control
Last updated May 17, 2026 05:48 UTC
-
New drug combo shows promise for tough breast cancer
Disease control Recruiting nowThis early-phase study tests two drugs, palbociclib and avelumab, together for people with a specific type of advanced breast cancer (AR+ triple-negative). The main goals are to find the safest doses and see if the combination can shrink tumors. About 45 participants with advance…
Matched conditions: RECURRENT BREAST CANCER
Phase: PHASE1 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Disease control
Last updated May 17, 2026 05:32 UTC